A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer
Authors
Keywords
HER2, Immunohistochemistry, Fluorescence in situ hybridization, Breast cancer, Meta-analysis
Journal
Breast Cancer
Volume 22, Issue 6, Pages 615-625
Publisher
Springer Nature
Online
2014-04-09
DOI
10.1007/s12282-014-0528-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Image Analysis of HER2 Immunohistochemical Staining
- (2012) Douglas M. Minot et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Comparison of four immunohistochemical tests and FISH for measuring Her2 expression in gastric carcinomas
- (2012) Eun Yoon Cho et al. PATHOLOGY
- Differential Response of Immunohistochemically Defined Breast Cancer Subtypes to Anthracycline-Based Adjuvant Chemotherapy with or without Paclitaxel
- (2012) George Fountzilas et al. PLoS One
- High Concordance Between Two Companion Diagnostics Tests
- (2011) Jan Trøst Jørgensen et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- A Comparison of Equivocal Immunohistochemical Results With Anti-HER2/neu Antibodies A0485 and SP3 With Corresponding FISH Results in Routine Clinical Practice
- (2011) Elizabeth Manion et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Human Epidermal Growth Factor Receptor 2 Testing in Gastroesophageal Cancer: Correlation Between Immunohistochemistry and Fluorescence In Situ Hybridization
- (2011) Laura J. Tafe et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer
- (2011) Zsuzsanna Varga et al. BREAST CANCER RESEARCH AND TREATMENT
- Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?
- (2011) Young Soo Park et al. HUMAN PATHOLOGY
- A case of HER-2-positive recurrent breast cancer showing a clinically complete response to trastuzumab-containing chemotherapy after primary treatment of triple-negative breast cancer
- (2011) Hideo Shigematsu et al. World Journal of Surgical Oncology
- The Reliability of Rabbit Monoclonal Antibodies in the Immunohistochemical Assessment of Estrogen Receptors, Progesterone Receptors, and HER2 in Human Breast Carcinomas
- (2010) Anthony Rhodes et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Achieving 95% Cross-Methodological Concordance in HER2 Testing
- (2010) Erin E. Grimm et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up
- (2010) Lisa Rydén et al. BREAST CANCER RESEARCH AND TREATMENT
- Pathologic Complete Response to Preoperative Sequential Doxorubicin/Cyclophosphamide and Single-Agent Taxane With or Without Trastuzumab in Stage II/III HER2-Positive Breast Cancer
- (2010) Saranya Chumsri et al. Clinical Breast Cancer
- Phase II Trial of Weekly Nanoparticle Albumin-Bound Paclitaxel With Carboplatin and Trastuzumab as First-line Therapy for Women With HER2-Overexpressing Metastatic Breast Cancer
- (2010) Alison K. Conlin et al. Clinical Breast Cancer
- Reliability of Her2/neu, estrogen receptor, and progesterone receptor testing by immunohistochemistry on cell block of FNA and serous effusions from patients with primary and metastatic breast carcinoma
- (2010) Ahmed Shabaik et al. DIAGNOSTIC CYTOPATHOLOGY
- HER2 Signatures in Breast Cancer: Ready to Go to Print?
- (2010) Pieter J.A. Eichhorn et al. JOURNAL OF CLINICAL ONCOLOGY
- Relationship between pathological features, HER2 protein expression and HER2 and CEP17 copy number in breast cancer: biological and methodological considerations
- (2010) K. Lambein et al. JOURNAL OF CLINICAL PATHOLOGY
- An Immunohistochemical and Fluorescence In Situ Hybridization-based Comparison Between the Oracle HER2 Bond Immunohistochemical System, Dako HercepTest, and Vysis PathVysion HER2 FISH Using Both Commercially Validated and Modified ASCO/CAP and United Kingdom HER2 IHC Scoring Guidelines
- (2010) Anthony OʼGrady et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Justification of the Change From 10% to 30% for the Immunohistochemical HER2 Scoring Criterion in Breast Cancer
- (2009) Yan-Hui Liu et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Emerging Technologies for Assessing HER2 Amplification
- (2009) Frédérique Penault-Llorca et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer
- (2009) Miguel Martín et al. BREAST CANCER RESEARCH AND TREATMENT
- Immunohistochemical detection of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast carcinomas
- (2009) Krisztina Z. Hanley et al. CANCER CYTOPATHOLOGY
- Disease-Free Survival According to Degree ofHER2Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial
- (2009) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Validation of the 4B5 rabbit monoclonal antibody in determining Her2/neu status in breast cancer
- (2009) Bert van der Vegt et al. MODERN PATHOLOGY
- HER2-testing in 538 consecutive breast cancer cases using FISH and immunohistochemistry
- (2009) Anikó Kovács et al. PATHOLOGY RESEARCH AND PRACTICE
- Tissue Microarrays for Routine Diagnostic Assessment of HER2 Status in Breast Carcinoma
- (2009) Primož Drev et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- What Causes Discrepancies in HER2 Testing for Breast Cancer?
- (2008) Shinobu Umemura et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Quantitative PCR and HER2 Testing in Breast Cancer
- (2008) Massimo Barberis et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The Equivocally AmplifiedHER2FISH Result on Breast Core Biopsy
- (2008) Joan M. Striebel et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy
- (2008) J. A. Gilbert et al. MOLECULAR CANCER THERAPEUTICS
- Immunohistochemical Antibodies in Breast Cancer HER2 Diagnostics
- (2008) Kristof Egervari et al. TUMOR BIOLOGY
- Re: A New Rabbit Monoclonal Antibody (4B5) for the Immunohistochemical (IHC) Determination of the HER2 Status in Breast Cancer: Comparison With CB11, Fluorescence In Situ Hybridization (FISH), and Interlaboratory Reproducibility
- (2008) Kristof Egervari et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now